NCT01146561 Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis Status TERMINATED Phase PHASE2
NCT01146327 A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects Status COMPLETED Phase PHASE1
NCT01145352 Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] Status COMPLETED Phase N/A
NCT01143805 A Study To Estimate The Amount Of CP-690,550 (Study Drug) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of CP-690,550 In Tablet Form Status COMPLETED Phase PHASE1
NCT01140737 A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas Status COMPLETED Phase PHASE2
NCT01140672 A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01140425 Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects Status COMPLETED Phase PHASE1
NCT01140412 Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects Status TERMINATED Phase PHASE1
NCT01137708 CP-690,550 And Oral Contraception Drug-Drug Interaction Study Status COMPLETED Phase PHASE1
NCT01137292 Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection Status COMPLETED Phase N/A
NCT01135511 A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease Status COMPLETED Phase PHASE2
NCT01133210 Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I) Status COMPLETED Phase PHASE1
NCT01132690 A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease Status COMPLETED Phase PHASE4
NCT01129258 Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01128712 Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin Status TERMINATED Phase PHASE4
NCT01128439 Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease Status COMPLETED Phase N/A
NCT01128426 Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers Status COMPLETED Phase N/A
NCT01127906 Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin Status COMPLETED Phase PHASE1
NCT01127893 Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis Status TERMINATED Phase PHASE3